ANI Pharmaceuticals
ANIP
#5022
Rank
NZ$2.82 B
Marketcap
NZ$125.82
Share price
-0.83%
Change (1 day)
9.21%
Change (1 year)

ANI Pharmaceuticals (ANIP) - Total debt

Total debt on the balance sheet as of December 2025 : NZ$1.05 Billion

According to ANI Pharmaceuticals's latest financial reports the company's total debt is NZ$1.05 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

ANI Pharmaceuticals - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2025-12-31NZ$1.06 B-3.72%
2024-12-31NZ$1.10 B144.97%
2023-12-31NZ$0.45 B0.1%
2022-12-31NZ$0.45 B7.26%
2021-12-31NZ$0.42 B63.48%
2020-12-31NZ$0.25 B-6.69%
2019-12-31NZ$0.27 B1.09%
2018-12-31NZ$0.27 B-3.84%
2017-12-31NZ$0.28 B62.91%
2016-12-31NZ$0.17 B5.09%
2015-12-31NZ$0.16 B21.88%
2014-12-31NZ$0.13 B
2013-12-31N/A-100%
2012-12-31NZ$9.58 M-56.86%
2011-12-31NZ$22.21 M-7.6%
2010-12-31NZ$24.04 M4.71%
2009-12-31NZ$22.96 M
2000-12-31NZ$1.12 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
NZ$60.71 B 5,633.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$109.77 B 10,265.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
NZ$15.49 B 1,362.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
NZ$9.30 B 779.02%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
NZ$8.77 M-99.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$4 M-99.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$29.33 B 2,670.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Royalty Pharma
RPRX
NZ$15.36 B 1,350.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
NZ$1.09 B 3.66%๐Ÿ‡บ๐Ÿ‡ธ USA